Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Thermogenesis Holdings Inc's Business Segments
Thermogenesis Holdings Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2024
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 2
Countrys Reported
2
Thermogenesis Holdings Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Country - Q1 FY2024
- US93.7%
- SG2.5%
Revenue by Geographic Country - Q1 FY2024
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| US | $ 2 | 93.7% |
| SG | $ 0 | 2.5% |
Revenue by Product & Service Category - Q1 FY2024
- Device Revenue86.3%
- Other4.5%
- Service2.9%
Revenue by Product & Service Category - Q1 FY2024
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Device Revenue | $ 2 | 86.3% |
| Other | $ 0 | 4.5% |
| Service | $ 0 | 2.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Thermogenesis Holdings Inc
Thermogenesis Holdings Inc is a publicly traded company operating in the biomedical technology sector. The company specializes in the development, manufacturing, and distribution of innovative regenerative medicine products and technologies. It focuses on addressing unmet medical needs in the field of cell therapy and bioprocessing.
Thermogenesis has a rich history that dates back to its establishment in 1986. Originally founded as a provider of cryopreservation tools and services, the company has evolved over the years to become a leader in the regenerative medicine industry. The company's strong commitment to research and development has allowed it to pioneer cutting-edge technologies and offer breakthrough solutions to medical professionals and researchers worldwide.
The company's flagship product is the AXP® AutoXpress® Platform, which enables the collection and processing of hematopoietic stem cells from umbilical cord blood. This innovative system streamlines and automates the process, ensuring the viability and quality of stem cell collections for transplantation and research purposes. The AXP platform has gained significant recognition and is widely used by healthcare institutions and cord blood banks globally.
Thermogenesis also offers a range of other products and services that support the field of regenerative medicine. This includes the BioArchive® System, a fully automated cryogenic storage system for the long-term preservation of stem cells and other biological samples. The company's ThermoGenesis® Cell Processing System (CP2) is another notable product, allowing researchers to isolate and expand cell populations for a wide range of therapeutic applications.
In addition to its device offerings, Thermogenesis provides comprehensive services to support its customers. This includes technical support, training programs, and regulatory guidance to ensure compliance with industry standards and regulations. The company's experienced team of scientists and engineers work closely with customers to provide personalized solutions tailored to their specific needs.
Thermogenesis has a strong global presence, with distribution networks spanning over 30 countries worldwide. Its products are widely recognized for their quality, reliability, and performance, making Thermogenesis a trusted partner for healthcare institutions, biotechnology companies, and researchers.
The company is consistently focused on innovation and has a robust pipeline of new products and technologies under development. This includes advancements in cell and gene therapy manufacturing processes, as well as the exploration of new therapeutic applications for stem cells. Thermogenesis strives to be at the forefront of regenerative medicine, anticipating market needs and driving forward the development of novel therapies.
In summary, Thermogenesis Holdings Inc is a leading biotechnology company specializing in regenerative medicine. With its innovative products, advanced technologies, and comprehensive services, the company is dedicated to improving patient outcomes and advancing the field of regenerative medicine. Through its commitment to research, development, and customer support, Thermogenesis is well-positioned for sustained growth and success in the biomedical technology industry.
Thermogenesis has a rich history that dates back to its establishment in 1986. Originally founded as a provider of cryopreservation tools and services, the company has evolved over the years to become a leader in the regenerative medicine industry. The company's strong commitment to research and development has allowed it to pioneer cutting-edge technologies and offer breakthrough solutions to medical professionals and researchers worldwide.
The company's flagship product is the AXP® AutoXpress® Platform, which enables the collection and processing of hematopoietic stem cells from umbilical cord blood. This innovative system streamlines and automates the process, ensuring the viability and quality of stem cell collections for transplantation and research purposes. The AXP platform has gained significant recognition and is widely used by healthcare institutions and cord blood banks globally.
Thermogenesis also offers a range of other products and services that support the field of regenerative medicine. This includes the BioArchive® System, a fully automated cryogenic storage system for the long-term preservation of stem cells and other biological samples. The company's ThermoGenesis® Cell Processing System (CP2) is another notable product, allowing researchers to isolate and expand cell populations for a wide range of therapeutic applications.
In addition to its device offerings, Thermogenesis provides comprehensive services to support its customers. This includes technical support, training programs, and regulatory guidance to ensure compliance with industry standards and regulations. The company's experienced team of scientists and engineers work closely with customers to provide personalized solutions tailored to their specific needs.
Thermogenesis has a strong global presence, with distribution networks spanning over 30 countries worldwide. Its products are widely recognized for their quality, reliability, and performance, making Thermogenesis a trusted partner for healthcare institutions, biotechnology companies, and researchers.
The company is consistently focused on innovation and has a robust pipeline of new products and technologies under development. This includes advancements in cell and gene therapy manufacturing processes, as well as the exploration of new therapeutic applications for stem cells. Thermogenesis strives to be at the forefront of regenerative medicine, anticipating market needs and driving forward the development of novel therapies.
In summary, Thermogenesis Holdings Inc is a leading biotechnology company specializing in regenerative medicine. With its innovative products, advanced technologies, and comprehensive services, the company is dedicated to improving patient outcomes and advancing the field of regenerative medicine. Through its commitment to research, development, and customer support, Thermogenesis is well-positioned for sustained growth and success in the biomedical technology industry.
As of my last available knowledge, Thermogenesis Holdings Inc. focuses primarily on the development and commercialization of innovative technologies in the field of regenerative medicine and stem cell therapies. The company’s offerings can be categorized into several key segments, products, and services which are summarized below:
Segments
1. Regenerative Medicine: This segment focuses on developing technologies that assist in the manipulation and preservation of cellular therapies, aiming to enhance patient outcomes through innovative products.
2. Cell Processing and Storage: Thermogenesis provides solutions for the processing and storage of various types of cells, including stem cells, which are vital for many therapeutic applications.
3. Commercialization of Proprietary Technology: The company focuses on bringing cutting-edge technologies to the market, often through partnerships or collaborations with other entities involved in regenerative medicine and cellular therapies.
Products
1. Automated Cell Processing Systems: Thermogenesis designs and manufactures automated systems that enable the rapid and efficient processing of cellular materials. These systems help improve the viability and functionality of the cells being prepared for therapeutic applications.
2. Cryopreservation Solutions: A range of products that allow for the safe freezing and long-term storage of cellular materials. These solutions are engineered to maintain cell integrity and viability during the freezing and thawing processes.
3. Cellular Therapy Kits: These kits contain all necessary components for clinicians to process and utilize cells in therapeutic settings. They are designed for ease of use and compliance with industry standards.
4. Regulatory Compliant Solutions: Products designed specifically to meet the stringent requirements set by regulatory bodies for the processing and storage of human cells for therapeutic purposes. This includes documentation, tracking, and quality assurance measures.
5. Biologics and Cell-Based Products: Thermogenesis may offer biologics that are derived from human cells or stem cells, serving various therapeutic applications, particularly in the fields of orthopedics and wound healing.
Services
1. Technical Support and Training: Thermogenesis provides extensive technical support and training services to healthcare providers and research institutions to ensure optimal use of their products. This can include on-site training, user manuals, and customer service assistance.
2. Consultation Services: Offering expertise in cell therapy and regenerative medicine applications, providing advisory services aimed at helping clients navigate the complexities of cell processing and therapy implementation.
3. Research and Development Partnerships: Thermogenesis engages in collaborative R&D efforts with academic institutions and corporate partners to innovate and develop new products and technologies in the regenerative medicine space.
4. Custom Solutions Development: The company may work with clients to develop tailored solutions that fit specific needs within the realm of cell processing and therapeutic applications.
5. Regulatory Assistance: Services to assist clients in navigating the regulatory landscape concerning stem cell research and applications, including preparation for clinical trials and compliance with health authority requirements.
Conclusion
Thermogenesis Holdings Inc. is positioned at the intersection of technology and healthcare, particularly in regenerative medicine and cell-based therapies. Their extensive array of products and services is designed to support the growing field of regenerative medicine, aiming to enhance treatment outcomes for patients requiring cellular therapies. The companys focus on innovation, quality, and compliance underscores its commitment to advancing medical science through cutting-edge technologies and solutions.
Segments
1. Regenerative Medicine: This segment focuses on developing technologies that assist in the manipulation and preservation of cellular therapies, aiming to enhance patient outcomes through innovative products.
2. Cell Processing and Storage: Thermogenesis provides solutions for the processing and storage of various types of cells, including stem cells, which are vital for many therapeutic applications.
3. Commercialization of Proprietary Technology: The company focuses on bringing cutting-edge technologies to the market, often through partnerships or collaborations with other entities involved in regenerative medicine and cellular therapies.
Products
1. Automated Cell Processing Systems: Thermogenesis designs and manufactures automated systems that enable the rapid and efficient processing of cellular materials. These systems help improve the viability and functionality of the cells being prepared for therapeutic applications.
2. Cryopreservation Solutions: A range of products that allow for the safe freezing and long-term storage of cellular materials. These solutions are engineered to maintain cell integrity and viability during the freezing and thawing processes.
3. Cellular Therapy Kits: These kits contain all necessary components for clinicians to process and utilize cells in therapeutic settings. They are designed for ease of use and compliance with industry standards.
4. Regulatory Compliant Solutions: Products designed specifically to meet the stringent requirements set by regulatory bodies for the processing and storage of human cells for therapeutic purposes. This includes documentation, tracking, and quality assurance measures.
5. Biologics and Cell-Based Products: Thermogenesis may offer biologics that are derived from human cells or stem cells, serving various therapeutic applications, particularly in the fields of orthopedics and wound healing.
Services
1. Technical Support and Training: Thermogenesis provides extensive technical support and training services to healthcare providers and research institutions to ensure optimal use of their products. This can include on-site training, user manuals, and customer service assistance.
2. Consultation Services: Offering expertise in cell therapy and regenerative medicine applications, providing advisory services aimed at helping clients navigate the complexities of cell processing and therapy implementation.
3. Research and Development Partnerships: Thermogenesis engages in collaborative R&D efforts with academic institutions and corporate partners to innovate and develop new products and technologies in the regenerative medicine space.
4. Custom Solutions Development: The company may work with clients to develop tailored solutions that fit specific needs within the realm of cell processing and therapeutic applications.
5. Regulatory Assistance: Services to assist clients in navigating the regulatory landscape concerning stem cell research and applications, including preparation for clinical trials and compliance with health authority requirements.
Conclusion
Thermogenesis Holdings Inc. is positioned at the intersection of technology and healthcare, particularly in regenerative medicine and cell-based therapies. Their extensive array of products and services is designed to support the growing field of regenerative medicine, aiming to enhance treatment outcomes for patients requiring cellular therapies. The companys focus on innovation, quality, and compliance underscores its commitment to advancing medical science through cutting-edge technologies and solutions.